glp-1 gip medications muscle loss comparison Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational only—these are Glucagon-like peptide-1 receptor agonists and

This is due to research showing how a diet that is low in glycaemic load can help stabilise blood sugar levels and therefore help optimise brain function

This group creates the largest care pathway because chronic weight management needs repeated clinical review

Rojas M, Ascencio F, Conway PL (2002) Purification and characterization of a surface protein from Lactobacillus fermentum 104R that binds to porcine small intestinal mucus and gastric mucin

Management of Hyperglycemia in Type 2 Diabetes, A consensus report by the american diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

They can also cause weight gain

H.TravagliR